BSECompany Update6d ago · 14 Aug 2026, 06:43 pm
Transcript of Earning call held on Wednesday, August 12, 2026 for analyst / Investors to discuss the Unaudited Financial Results for the quarter ended June 30, 2026
Jyothy Labs Ltd · 532926
✦ AI SummaryResults
Jyothy Labs Ltd's Q1 FY27 earnings call transcript discusses the company's financial results for the quarter ended June 30, 2026, highlighting the impact of crude oil and crude-linked derivatives volatility on input costs, packaging materials, and supply chain planning. The company expects double-digit revenue growth for FY27, excluding the Pril business, but EBITDA margins are likely to remain under pressure due to elevated crude-linked input costs.
Analysis Scores
Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Attachments (1)
📄pdf
Download →
5bddef2a-6524-417c-bdfd-dc778621844b.pdf
View document text
August 14, 2026
BSE Limited N a t ional Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra – Kurla Complex,
Dalal Street, Mumbai – 400 023 Bandra (E), Mumbai – 400 051
BSE Code: 532926 Scrip Code: JYOTHYLAB
Dear Sir / Madam,
Sub: Transcript of the earnings conference call for the quarter ended June 30, 2026
Pursuant to Regulation 30(6) read with Part A of Para A of Schedule III of the SEBI (Listing
Obligations and Disclosure Requirements), Regulations 2015, transcript of the earnings
conference call held on Wednesday, August 12, 2026 for analyst/ investors to discuss the Un-
audited Financial Results for the quarter ended June 30, 2026 and the way forward, is
enclosed.
Further, the aforesaid information is also available on the website of the Company at
www.jyothylabs.com.
Kindly take the above on your record and disseminate the same for the information of
investors.
Thanking you,
Yours faithfully,
For Jyothy Labs Limited
Shreyas Trivedi
Head – Legal & Company Secretary
Encl.: as above
Jyothy Labs Limited
CIN: L24240MH1992PLC128651
‘Ujala House’, Ramkrishna Mandir Road,
Kondivita, Andheri (East), Mumbai 400059.
Tel: +91 022-6689 2800 | Fax: +91 022-6689 2805
info@jyothy.com | www.jyothylabs.com
“Jyothy Labs Limited
Q1 FY27 Earnings Conference Call”
August 12, 2026
MANAGEMENT: MS. M. R JYOTHY – CHAIRPERSON AND MANAGING
DIRECTOR – JYOTHY LABS LIMITED
MR. PAWAN AGARWAL – CHIEF FINANCIAL OFFICER –
JYOTHY LABS LIMITED
MODERATOR: MR. ANIKET KAMBLE – ICICI SECURITIES
Page 1 of 14
Jyothy Labs Limited
August 12, 2026
Moderator: Ladies and gentlemen, good day, and welcome to Jyothy Labs Q1 FY27 Earnings Conference
Call hosted by ICICI Securities. As a reminder, all participant lines will be in the listen-only
mode and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during this conference call, please signal an operator by pressing
star then zero on your touchtone phone. Please note that this conference is being recorded.
I now hand the conference over to Mr. Aniket Kamble from ICICI Securities. Thank you, and
over to you, sir.
Aniket Kamble Thank you, Yousuf. Hi. It's an absolute pleasure from ICICI Securities to host the Q1 FY27
earnings call for Jyothy Labs. From the management, we have Ms. Jyothy, Chairperson and
Managing Director; and Mr. Pawan Agarwal, CFO. I now hand over the call to Jyothy ma'am
for her opening remarks. Thank you, and over to you, ma'am.
M. R. Jyothy: Good afternoon, everyone, and a warm welcome to the Q1 FY27 earnings of Jyothy Labs
Limited. Our financial results and investor presentation are available on our website and the
stock exchanges. I trust you have had the opportunity to review them.
Let me begin with the broader operating environment. Rural demand stayed relatively resilient,
while urban markets after showing signs of recovery in the second half of FY26 remained
subdued during the quarter. Higher household expenses, continued pressure on discretionary
spends, and cautious consumer sentiment affected urban consumption.
Across the sector, companies are balancing commodity inflation through calibrated pricing,
premiumization, innovation, mix improvement, and sharper pack price architecture, while
protecting consumer affordability. We are, therefore, cautiously optimistic on the demand with
growth expected to be driven by a balanced combination of volume expansion, selective pricing,
premiumization and new product scale - up rather than the price increases alone.
During the quarter, crude oil and crude-linked derivatives remained highly volatile. The West
Asia conflict kept global energy markets unsettled. This affected input costs, packaging
materials, and the supply - chain planning. While the recent moderation in crude prices is
encouraging, we remain watchful of geopolitical developments and their lagged impact on cost
and margins.
Our immediate priority was to ensure continuity in production, supply and sales, and we largely
achieved that objective. However, the price increases taken towards the end of March and in
April were not sufficient to offset the unusually high raw material and packing cost inflation. In
addition, the company did not have any material benefit of lower-priced older inventory in the
With a large part of our business coming from Fabric Care and Home Care, where crude-linked
inputs play an important role, margins were significantly impacted during the quarter. In our
assessment, raw material and packaging costs are unlikely to correct immediately even if crude
prices remain moderate, as higher cost purchases and contracted inventories will continue to
flow through Q2.
Page 2 of 14
Jyothy Labs Limited
August 12, 2026
Any benefit from lower crude-linked inputs is likely to be visible only gradually and more
meaningfully from October, provided commodity prices remain stable. Margin recovery is
therefore expected to be progressive and closely linked to top line growth. That said, we believe
the current margin pressure is largely transitory and near-term in nature. As commodity prices
stabilize and volumes improve, operating leverage should support margin recovery over the
coming quarters.
For FY27, excluding the Pril business, we expect double-digit revenue growth. EBITDA
margins are likely to remain under pressure during the year due to elevated crude-linked input
costs, though H2 should be substantially better than H1, subject to demand momentum and
commodity price stability.
We are focused on cost optimization, supply chain efficiencies, procurement excellence, value
engineering, and selective pricing actions to restore profitability without compromising
competitiveness or market share. On channels, GT growth was muted largely due to lower urban
demand. However, all other channels put together delivered impressive growth.
Modern trade, e-commerce and quick commerce continued their strong momentum and remain
among our fastest-growing channels. A&P spends has been moderated over the past few quarters
due to input cost inflation. Going forward, we intend to step-up investments in advertising and
brand building to support long-term sustainable growth.
From Q1 FY27, we have aligned our segment reporting with the way management reviews the
business and allocates resources in accordance with the Ind AS 108. We will now report
performance under 3 segments, which is Fabric Care, Home Care, and Personal Care.
Fabric Care will continue to be reported separately given its scale and strategic importance.
Home Care brings together our key in-home consumption categories, while Personal Care
reflects the growth opportunity in that portfolio. We believe this revised structure gives investors
a clearer and more meaningful view of how we manage the business, allocate capital, drive
innovation and pursue long-term growth. Comparative numbers have been restated for
consistency.
Fabric Care maintained its strong momentum, delivering over 14% value growth and 10%
volume growth during the quarter. Detergent powders and bar grew in double digits, while liquid
detergents continued their high-growth journey across Henko, Ujala, Mr. White, and Morelight.
Home Care grew by 2.4% year-on-year, excluding Pril sales. Within Home Care, the Dishwash
portfolio was impacted by the Pril exit effective 31st May 2026.
However, the newly launched bioenzyme-based Exo Liquid has made encouraging progress
despite being at an early stage of scale-up and channel expansion. The broader Exo franchise
includes bars, powders, liquids, and scrubbers grew in mid- to high single-digits in value terms
and double digit in volume terms. In household insecticides, the extended summer and delayed
rainfall affected category performance in Q1.
Page 3 of 14
Jyothy Labs Limited
August 12, 2026
We have launched the Maxo incense sticks in July, to address the growing concern around unsafe
and unapproved local agarbathies. Maxo incense sticks is a safe and effective
[Showing first 8,000 characters — download PDF for full document]